deltatrials
Completed PHASE4 NCT00133718

A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control

Asker and Baerum Cardiovascular Diabetes Study

Sponsor: Asker & Baerum Hospital

Conditions Type 2 Diabetes Mellitus
Interventions Combined lifestyle intervention and optimisation of pharmacological treatment
Updated 9 times since 2017 Last updated: Jan 23, 2017 Started: Jan 31, 2002 Primary completion: Apr 30, 2006 Completion: May 29, 2012

Listed as NCT00133718, this PHASE4 trial focuses on Type 2 Diabetes Mellitus and remains completed. Sponsored by Asker & Baerum Hospital, it has been updated 9 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Mar 2025 — Sep 2025 [monthly]

    Completed PHASE4

  3. Feb 2025 — Mar 2025 [monthly]

    Completed PHASE4

  4. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE4

  5. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  2. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: Unknown Status → Completed · Phase: NA → PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Unknown Status NA

    First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Asker & Baerum Hospital
  • Rikshospitalet University Hospital
  • Sahlgrenska University Hospital
  • University Hospital, Aker
Data source: Asker & Baerum Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Rud, Norway